TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46

Benzinga · 1d ago
TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.